Literature DB >> 4164338

Effect of progestational agents on gonadal and adrenal cortical function in patients with benign prostatic hypertrophy and carcinoma of the prostate.

J Geller, B Fruchtman, C Meyer, H Newman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4164338     DOI： 10.1210/jcem-27-4-556

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  7 in total

1.  Pills for the benign prostate. Trial designs.

Authors:  J E Castro
Journal:  Proc R Soc Med       Date:  1972-02

2.  Inhibition of testosterone biosynthesis by medrogestone.

Authors:  M L Givner; D Dvornik
Journal:  Experientia       Date:  1972-09-15

3.  Shrinking the prostate.

Authors: 
Journal:  Br Med J       Date:  1970-03-07

Review 4.  Pharmacology and clinical use of antiandrogens: a short review.

Authors:  F Neumann
Journal:  Ir J Med Sci       Date:  1982-03       Impact factor: 1.568

5.  Gestagens in the management of prostatic carcinoma.

Authors:  Z Szendröi
Journal:  Int Urol Nephrol       Date:  1984       Impact factor: 2.370

6.  Immunological effect of hormones: a review.

Authors:  J E Castro
Journal:  J R Soc Med       Date:  1978-02       Impact factor: 18.000

7.  Suppression of the Hypothalamic-pituitary-adrenal Axis by Maximum Androgen Blockade in a Patient with Prostate Cancer.

Authors:  Takeshi Kondo; Itsuro Endo; Yukari Ooguro; Kana Morimoto; Kiyoe Kurahashi; Sumiko Yoshida; Akio Kuroda; Ken-Ichi Aihara; Munehide Matsuhisa; Masahiro Abe; Seiji Fukumoto
Journal:  Intern Med       Date:  2016-12-15       Impact factor: 1.271
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.